Treace Medical Concepts (TMCI) Capital Expenditures (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Capital Expenditures came in at $293000.0 in Q1 2026, down 91.73% YoY from $3.5 million in Q1 2025, and down 97.78% on a QoQ basis from $13.2 million in Q4 2025.
Treace Medical Concepts (TMCI) Capital Expenditures (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Capital Expenditures data on file, last reported at $293000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 91.73% year-over-year to $293000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (up 165.09% YoY) and the FY2025 annual result came in at $13.5 million, up 3996.06% from the prior year.
- Capital Expenditures slipped to $293000.0 in Q1 2026, from $13.2 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $15.0 million in Q4 2022 to a low of -$6.8 million in Q3 2022.
- A 5-year average of $2.7 million and a median of $1.5 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures slumped 684.64% — and 2025, when it surged 73311.11%.
- Tracing TMCI's Capital Expenditures over 5 years: stood at $15.0 million in 2022, then retreated by 23.53% to $11.5 million in 2023, then tumbled by 99.84% to $18000.0 in 2024, then surged by 73311.11% to $13.2 million in 2025, then slumped by 97.78% to $293000.0 in 2026.
- The last three Capital Expenditures figures came in at $293000.0 (Q1 2026), $13.2 million (Q4 2025), and -$62000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Treace Medical Concepts | 283.62 Mn | 238.00 Mn | 35.61 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Mn |
| Jun 30, 2026 | 2.20 Mn |
| Mar 31, 2026 | 293,000.00 |
| Mar 31, 2026 | 293,000.00 |
| Dec 31, 2025 | 13.21 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -3.18 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 312,000.00 |
| Sep 30, 2024 | 312,000.00 |
| Dec 31, 2023 | 11.46 Mn |
| Dec 31, 2023 | 11.46 Mn |
| Sep 30, 2023 | -5.71 Mn |
| Sep 30, 2023 | -5.71 Mn |